The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Xencor, a biotherapeutics company developing protein and antibody therapeutics,
today announced that it raised $6 million in a bridge financing from new investor
Novo Nordisk and existing investors including Zen Investments. Pursuant to the
bridge financing, Novo Nordisk has committed to invest an additional $6 million
in specified future financings.